Davis R M Inc. Increases Position in Stryker Co. (NYSE:SYK)

Davis R M Inc. boosted its holdings in shares of Stryker Co. (NYSE:SYK) by 2.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 123,960 shares of the medical technology company’s stock after purchasing an additional 3,279 shares during the quarter. Davis R M Inc.’s holdings in Stryker were worth $44,782,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Centennial Bank AR lifted its position in shares of Stryker by 106.7% during the 2nd quarter. Centennial Bank AR now owns 93 shares of the medical technology company’s stock valued at $32,000 after buying an additional 48 shares in the last quarter. Darwin Wealth Management LLC acquired a new position in Stryker during the third quarter worth $36,000. HBW Advisory Services LLC purchased a new position in Stryker during the third quarter valued at $42,000. Hara Capital LLC purchased a new position in Stryker during the third quarter valued at $42,000. Finally, Grove Bank & Trust grew its position in shares of Stryker by 84.8% in the third quarter. Grove Bank & Trust now owns 122 shares of the medical technology company’s stock valued at $44,000 after purchasing an additional 56 shares during the period. 77.09% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on SYK. Needham & Company LLC upped their price target on shares of Stryker from $393.00 to $409.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. BTIG Research increased their target price on Stryker from $383.00 to $394.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Stifel Nicolaus lowered their price target on Stryker from $375.00 to $365.00 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. Wells Fargo & Company boosted their price target on Stryker from $381.00 to $405.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Finally, Evercore ISI raised their price objective on Stryker from $380.00 to $384.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $393.65.

Insider Activity at Stryker

In related news, VP M Kathryn Fink sold 2,121 shares of the business’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $370.00, for a total value of $784,770.00. Following the sale, the vice president now owns 10,042 shares in the company, valued at approximately $3,715,540. The trade was a 17.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Viju Menon sold 600 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $355.00, for a total value of $213,000.00. Following the transaction, the insider now owns 9,069 shares of the company’s stock, valued at $3,219,495. This trade represents a 6.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 67,381 shares of company stock worth $24,825,275. Company insiders own 5.50% of the company’s stock.

Stryker Stock Down 1.4 %

Shares of NYSE SYK opened at $384.85 on Monday. Stryker Co. has a 1 year low of $285.79 and a 1 year high of $398.20. The company has a market capitalization of $146.71 billion, a P/E ratio of 41.25, a P/E/G ratio of 2.90 and a beta of 0.91. The company has a 50 day simple moving average of $366.20 and a 200-day simple moving average of $349.63. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.91 and a quick ratio of 1.22.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.77 by $0.10. Stryker had a return on equity of 23.07% and a net margin of 16.34%. The company had revenue of $5.49 billion during the quarter, compared to analysts’ expectations of $5.37 billion. During the same quarter last year, the firm earned $2.46 earnings per share. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts predict that Stryker Co. will post 12.06 earnings per share for the current year.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.